93 results
424B3
KZIA
Kazia Therapeutics Limited
1 May 24
Prospectus supplement
4:06pm
metabolites of EVT801 in plasma.
To determine preliminary anti-tumour activity of EVT801 via assessment of overall response rate.
We look forward
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
1 May 24
Kazia Reports Successful Stage 1 Completion of the EVT801
4:01pm
of EVT801 in plasma.
To determine preliminary anti-tumour activity of EVT801 via assessment of overall response rate.
We look forward to sharing the final
6-K
EX-99.2
KZIA
Kazia Therapeutics Limited
13 Oct 23
Current report (foreign)
4:08pm
rules in Division 230 of the Income Tax Assessment Act 1997 (Cth) in relation to gains and losses on their Shares.1
The information is based upon
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
. The consolidated entity’s assessment of the impact of these new or amended Accounting Standards and Interpretations is that none are deemed to have a material … criteria in AASB 112 Income Taxes (AASB 112) where there is uncertainty over income tax treatments and requires an assessment of each uncertain tax
6-K
EX-99.4
griagvti6fxj7r0kmnz0
5 Sep 23
Current report (foreign)
7:02am
6-K
EX-99.4
zxd 26sl29ja
1 Sep 22
Current report (foreign)
4:07pm
6-K
EX-99.1
5ko7w mvh9fi1bm4
1 Sep 22
Current report (foreign)
4:07pm
6-K
xfgxdsh66y 73ar
23 Jun 22
Current report (foreign)
7:40am
6-K
EX-1.1
vfcx4i0
22 Apr 22
Current report (foreign)
4:06pm
6-K
2ghx9r 1tcrwhukdi
3 Dec 21
Current report (foreign)
6:22am
6-K
p0z4o x7nubn
4 Jan 21
Current report (foreign)
6:05am
6-K
rj8rg 7wz
16 Oct 20
Current report (foreign)
6:04am
6-K
lhy8i11d5ia0
25 Feb 20
Current report (foreign)
6:07am